Trivedi, Ashit http://orcid.org/0000-0002-5040-5722
Kiang, Y.-H.
Saw, Robert E.
Cheng, Guilong Charles
Mather, Omar
Vega, Silvia
Hellawell, Jennifer
Lee, Edward
Funding for this research was provided by:
Amgen
Article History
Accepted: 14 March 2022
First Online: 12 April 2022
Declarations
:
: The study was funded by Amgen Inc.
: AT, Y-HK, RES, SV, JH, and EL are employees and stockholders of Amgen Inc. OM and GCC were employed by, and stockholders of, Amgen Inc. at the time of trial completion.
: Qualified researchers may request data from Amgen clinical studies; complete details are available at ExternalRef removed.
: Not applicable.
: All authors provided substantial contributions to the interpretation of data for the work, drafted and revised the manuscript critically for important intellectual content, and approved the final version to be published.
: The study was conducted at WCCT Global (Cypress, CA 90630, USA) following ethical guidelines of the Declaration of Helsinki and Council for International Organizations of Medical Sciences, applicable Good Clinical Practice guidelines of the International Council for Harmonization, and applicable local laws and regulations. The locally appointed ethics review board (IRBCo, Buena Park, CA 90621, USA) approved the research protocol.
: Written informed consent was obtained from all subjects.
: Not applicable.